The accompanying notes are an integral part
of these condensed consolidated financial statements.
The accompanying notes are an integral part
of these condensed consolidated financial statements.
The accompanying notes are an integral part
of these condensed consolidated financial statements.
The accompanying notes are an integral part
of these condensed consolidated financial statements.
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 —
Business Organization and Nature of Operations
Xspand Products
Lab, Inc. (“Xspand”) was incorporated on July 18, 2017 under the laws of the State of Nevada as Idea Lab X Products,
Inc. On October 26, 2017, Idea Lab X Products, Inc. changed its name to Xspand Products Lab, Inc.
As of March
31, 2018, Xspand had two wholly-owned subsidiaries (collectively, the “Company”): S.R.M. Entertainment Limited (“SRM”)
and Ferguson Containers, Inc. (“Fergco”). SRM was incorporated in Hong Kong on January 14, 1981 and primarily designs,
manufactures and sells a broad variety of innovative toy products directly to retailers or direct to consumers via ecommerce in
North America, Asia and Europe. Fergco was incorporated on September 14, 1966 under the laws of the State of New Jersey. Fergco
primarily designs, manufactures and sells packaging and packaging materials for industrial and pharmaceutical companies in North
America.
On September
30, 2017, SRM and Fergco were acquired by Xspand in exchange for an aggregate of 3,000,000 shares of Xspand common stock and notes
payable aggregating $2,996,500. This transaction between entities under common control resulted in a change in reporting
entity and required retrospective combination of the entities for all periods presented, as if the combination had been in effect
since the inception of common control. Accordingly, the consolidated financial statements of Xspand reflect the accounting of the
combined acquired subsidiaries at historical carrying values, except that equity reflects the equity of Xspand.
Note 2 —
Summary of Significant Accounting Policies
Basis of
Presentation
The condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United
States of America (“GAAP”) for interim financial statements and with Form 10-Q and Article 10 of Regulation S-X of
the United States Securities and Exchange Commission. Accordingly, they do not contain all information and footnotes required
by GAAP for annual financial statements. The condensed consolidated financial statements include the accounts of the Company and
its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion
of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments
necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2018
and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March
31, 2018 are not necessarily indicative of the operating results for the full fiscal year for any future period.
These condensed consolidated financial statements should be read in conjunction with the consolidated
financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December
31, 2017. The Company’s accounting policies are described in the Notes to Consolidated Financial Statements in its Annual
Report on Form 10-K for the year ended December 31, 2017, and updated, as necessary, in this Quarterly Report on Form 10-Q.
Principles
of Consolidation
The
condensed consolidated financial statements include the accounts of Xspand and its wholly-owned subsidiaries, SRM and Fergco.
All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates
Preparation
of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect
the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the
financial statements.
The Company’s
significant estimates used in these financial statements include, but are not limited to, accounts receivable reserves, the valuation
allowance related to the Company’s deferred tax assets and the recoverability and useful lives of long-lived assets. Certain
of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic
conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could
cause actual results to differ from those estimates.
Xspand Products Lab,
Inc. and Subsidiaries?
NOTES TO THE
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 2 —
Summary of Significant Accounting Policies — (Continued)
Inventory
Inventory is
recorded at the lower of cost or net realizable value on a first-in, first-out basis. The Company reduces the carrying value of
inventories for those items that are potentially excess, obsolete, or slow moving based on changes in customer demand, technology
developments, or other economic factors.
Revenue Recognition
Generally the
Company considers all revenues as arising from contracts with customers. Revenue is recognized based on the five step process outlined
in the Accounting Standards Codification (“ASC”) 606:
Step 1 –
Identify the Contract with the Customer – A contract exists when (a) the parties to the contract have approved the contract
and are committed to perform their respective obligations, (b) the entity can identify each party’s rights regarding the
goods or services to be transferred, (c) the entity can identify the payment terms for the goods or services to be transferred,
(d) the contract has commercial substance and € it is probably that the entity will collect substantially all of the consideration
to which it will be entitled in exchange for the goods or services that will be transferred to the customer.
Step 2 –
Identify Performance Obligations in the Contract – Upon execution of a contract, the Company identifies as performance obligations
each promise to transfer to the customer either (a) goods or services that are distinct or (b) a series of distinct goods or services
that are substantially the same and have the same pattern of transfer to the customer. To the extent a contract includes multiple
promised goods or services, the Company must apply judgement to determine whether the goods or services are capable of being distinct
within the context of the contract. If these criteria are not met, the goods or services are accounted for as a combined performance
obligation.
Step 3 –
Determine the Transaction Price – When (or as) a performance obligation is satisfied, the Company shall recognize as revenue
the amount of the transaction price that is allocated to the performance obligation. The contract terms are used to determine the
transaction price. Generally, all contracts include fixed consideration. If a contract did include variable consideration, the
Company would determine the amount of variable consideration that should be included in the transaction price based on expected
value method. Variable consideration would be included in the transaction price, if in the Company’s judgement, it is probable
that a significant future reversal of cumulative revenue under the contract would not occur.
Step 4 –
Allocate the Transaction Price – After the transaction price has been determined, the next step is to allocate the transaction
price to each performance obligation in the contract. If the contract only has one performance obligation, the entire transaction
price will be applied to that obligation. If the contract has multiple performance obligations, the transaction price is allocated
to the performance obligations based on the relative standalone selling price (SSP) at contract inception.
Xspand Products Lab,
Inc. and Subsidiaries
NOTES TO THE
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 2 —
Summary of Significant Accounting Policies — (Continued)
Step 5 –
Satisfaction of the Performance Obligations (and Recognize Revenue) – Revenue is recognized when (or as) goods or services
are transferred to a customer. The Company satisfies each of its performance obligations by transferring control of the promised
good or service underlying that performance obligation to the customer. Control is the ability to direct the use of, and obtain
substantially all of the remaining benefits from an asset. It includes the ability to prevent other entities from directing the
use of, and obtaining the benefits from an asset. Indicators that control has passed to the customer include: a present obligation
to pay; physical possession of the asset; legal title; risks and rewards of ownership; and acceptance of the asset(s). Performance
obligations can be satisfied at a point in time or over time.
Substantially
all of the Company’s revenues continue to be recognized when control of the goods are transferred to the customer, which
is upon shipment of the finished goods to the customer. All sales have fixed pricing and there are currently no variable components
included in the Company’s revenue. Additionally, the Company will issue credits for defective merchandise, historically
these credits for defective merchandise have not been material. Based on the Company’s analysis of the new revenue standards,
revenue recognition from the sale of finished goods to customers, which represents substantially all of the Company’s revenues,
was not impacted by the adoption of the new revenue standards.
Disaggregation
of Revenue
The Company’s
primary revenue streams include the sale of goods for innovative toy products (SRM) and packaging materials to industrial and
pharmaceutical companies (Fergco).
For a presentation
of the Company’s revenues disaggregated by segment, see Note 9, Segment Reporting.
Fair Value
of Financial Instruments
The Company
measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and
Disclosures” (“ASC 820”) which defines fair value, establishes a framework for measuring fair value, and expands
disclosures about fair value measurements.
ASC 820 defines
fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal
or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement
date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize
the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure
fair value:
Level 1 —
quoted prices in active markets for identical assets or liabilities
Level 2 —
quoted prices for similar assets and liabilities in active markets or inputs that are observable
Level 3
— inputs that are unobservable (for example, cash flow modeling inputs based on assumptions)
The carrying
amounts of the Company’s financial instruments, such as cash, accounts receivable, accounts payable, accrued expenses and
other current liabilities approximate fair values due to the short-term nature of these instruments. The carrying amount of the
Company’s notes payable approximates fair value because the effective yields on these obligations, which include contractual
interest rates, taken together with other features such as concurrent issuance of warrants, are comparable to rates of returns
for instruments of similar credit risk.
Foreign Currency
Translation
The Company
uses the United States dollar as its functional and reporting currency since the majority of the Company’s revenues, expenses,
assets and liabilities are in the United States. Assets and liabilities in foreign currencies (HK dollars) are translated using
the exchange rate at the balance sheet date, while revenue and expense accounts are translated at the average exchange rates prevailing
during the year. Equity accounts are translated at historical exchange rates. Gains and losses from foreign currency transactions
and translation for the three months ended March 31, 2018 and 2017 and the cumulative translation gains and losses as of March
31, 2018 and December 31, 2017 were not material.
Xspand Products Lab,
Inc. and Subsidiaries
NOTES TO THE
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 2 —
Summary of Significant Accounting Policies — (Continued)
Income Taxes
The Company
accounts for income taxes under the provisions of the Financial Accounting Standards Board (“FASB”) ASC Topic 740 “Income
Taxes” (“ASC Topic 740”).
The Company
recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded
in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between
the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”)
at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.
The Company
utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return.
Management
has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s
condensed consolidated financial statements as of March 31, 2018 and December 31, 2017. The Company does not expect any
significant changes in its unrecognized tax benefits within twelve months of the reporting date.
The Company’s
policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative
expenses in the statements of operations.
On December 22, 2017, the Tax
Cuts and Jobs Act (the “TCJA”) was signed into law. This legislation significantly changes U.S. tax law by, among other
things, lowering corporate income tax rates, implementing a territorial tax system and imposing a repatriation tax on deemed repatriated
earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from 35% to 21%, effective
January 1, 2018.
The staff of the Securities
and Exchange Commission issued Staff Accounting Bulletin No. 118 to address the application of GAAP in situations when a registrant
does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete
the accounting for certain income tax effects of the TCJA. Although the Company is unable to make a reasonable estimate on the
full effect on our income taxes as of the date of this report, the Company remeasured its deferred tax assets and liabilities based
on the rates at which they are expected to reverse in the future, which is generally 21%. The remeasurement of the Company's deferred
tax assets and liabilities was offset by a change in the valuation allowance.
The Company is still in
the process of analyzing the impact to the Company of the TCJA. Where the Company has been able to make reasonable estimates
of the effects related to which its analysis is not yet complete, the Company has recorded provisional amounts. The ultimate
impact to the Company’s condensed consolidated financial statements of the TCJA may differ from the provisional amounts
due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional
regulatory guidance that may be issued, and actions the Company may take as a result of the TCJA. The accounting is expected
to be complete when the Company’s 2017 U.S. corporate income tax return is filed in 2018.
Earnings
Per Share
Basic net
(loss) income per common share is computed by dividing net (loss) income by the weighted average number of vested common shares
outstanding during the period, adjusted to give effect to the 1-for-3.333333 reverse stock split, which was effected on February
14, 2018. Diluted net income per common share is computed by dividing net income by the weighted average number vested of common
shares, plus the net impact of common shares (computed using the treasury stock method), if dilutive, resulting from the exercise
of dilutive securities. As of March 31, 2018 and 2017, there were no dilutive securities outstanding.
Xspand Products Lab,
Inc. and Subsidiaries
NOTES TO THE
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 2 —
Summary of Significant Accounting Policies — (Continued)
Concentrations
Financial instruments
that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivables
and revenues.
The Company
has cash on deposits in several financial institutions which, at times, may be in excess of Federal Deposit Insurance Corporation
(“FDIC”) insurance limits. The Company has not experienced losses in such accounts and periodically evaluates the creditworthiness
of its financial institutions. The Company reduces its credit risk by placing its cash and cash equivalents with major financial
institutions. The Company had $534,666 uninsured at March 31, 2018 and $131,183 uninsured at December 31, 2017. The Company held
cash of $445,481 in foreign bank accounts as of March 31, 2018.
The Company
had revenues to two customers that represented 35% and 13% of total net sales for the three months ended March 31, 2018. The Company
had revenues to one customer that represented 28% of total net sales for the three months ended March 31, 2017.
The Company
had accounts receivables to one customer that represented 42% and 33% of total accounts receivable as of March 31, 2018 and December
31, 2017.
The Company
had revenues in the United Stated of approximately 61% and 68% of total consolidated revenues for the three months ended March
31, 2018 and 2017, respectively. No other geographical area accounted for more than 10% of total sales during the three months
ended March 31, 2018 and 2017.
Deferred
Financing Costs
Deferred financing
costs include debt discounts and debt issuance costs related to a recognized debt liability and are presented in the balance sheet
as a direct deduction from the carrying value of the debt liability. Amortization of deferred financing costs are included as a
component of interest expense.
Deferred
Offering Costs
Costs directly
attributable to an offering of equity securities were deferred and will be charged against the gross proceeds of the offering as
a reduction of additional paid-in capital at the time of the initial public offering (“IPO”). These costs included
legal fees to draft the registration statement and provide counsel, fees incurred by the independent registered public accounting
firm directly related to the offering, fees incurred by financial reporting advisors directly related to the offering, SEC filing,
printing and distribution expenses, roadshow expenses and exchange listing fees.
Subsequent
Events
The Company
has evaluated subsequent events through the date which the financial statements were issued. Based upon the evaluation, except
for items described in Note 10, the Company did not identify any recognized or non-recognized subsequent events that would have
required adjustment or disclosure in the financial statements.
Segment Reporting
The Company
uses “the management approach” in determining reportable operating segments. The management approach considers the
internal organization and reporting used by the Company’s chief operating decision maker for making operating decisions and
assessing performance as the source for determining the Company’s reportable segments. The Company’s chief operating
decision maker is the Chairman and chief executive officer (“CEO”) of the Company, who reviews operating results to
make decisions about allocating resources and assessing performance for the entire Company. The Company classified the reportable
operating segments into (i) design, manufacture and sale of a broad variety of innovative toy products sold directly to retailers
or direct to consumers via ecommerce in North America, Asia and Europe by SRM and (ii) the design, manufacture and sale of packaging
and packaging materials to industrial and pharmaceutical companies in North America by Fergco.
Note 3 —
Inventory
As of March
31, 2018 and December 31, 2017, inventory consisted of the following:
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2018
|
|
|
2017
|
|
Raw materials
|
|
$
|
6,489
|
|
|
$
|
30,410
|
|
Finished goods
|
|
|
217,087
|
|
|
|
209,651
|
|
Total inventory
|
|
$
|
223,576
|
|
|
$
|
240,061
|
|
Xspand Products Lab,
Inc. and Subsidiaries
NOTES TO THE
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 4 — Income Taxes
United States and foreign components
of income before income taxes were as follows:
|
|
For the Three Months Ended March 31,
|
|
|
|
2018
|
|
|
2017
|
|
United States
|
|
$
|
(2,059,485
|
)
|
|
$
|
51,583
|
|
Foreign
|
|
|
547,253
|
|
|
|
531,597
|
|
(Loss) income before income taxes
|
|
$
|
(1,512,232
|
)
|
|
$
|
583,180
|
|
Fergco was a Subchapter S pass-through
entity for income tax purposes prior to the acquisition by Xspand on September 30, 2017. Accordingly, Fergco was not subject to
income taxes prior to the acquisition and therefore the tax provision related to the United States income is only for the period
from January 1, 2018 to March 31, 2018.
The Company’s foreign
entity is SRM, which is an entity subject to the Hong Kong, China tax regime. The Hong Kong tax returns remain subject to examination
by local taxing authorities beginning with the tax year ended December 31, 2011.
The tax effects of temporary
differences that give rise to deferred tax assets or liabilities are presented below:
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2018
|
|
|
2017
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Net operating loss carryforwards
|
|
$
|
501,543
|
|
|
$
|
50,524
|
|
Less: valuation allowance
|
|
|
(501,543
|
)
|
|
|
(50,524
|
)
|
Net deferred tax assets
|
|
|
-
|
|
|
|
-
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Property and equipment
|
|
|
34,209
|
|
|
|
34,209
|
|
Deferred tax liabilities
|
|
|
34,209
|
|
|
|
34,209
|
|
Net deferred tax liabilities
|
|
$
|
34,209
|
|
|
$
|
34,209
|
|
The income tax provision
consists of the following:
|
|
For the Three Months Ended March 31,
|
|
|
|
2018
|
|
|
2017
|
|
Current:
|
|
|
|
|
|
|
Federal
|
|
$
|
18,741
|
|
|
$
|
-
|
|
Foreign
|
|
|
41,044
|
|
|
|
43,739
|
|
State and local
|
|
|
5,288
|
|
|
|
-
|
|
Income tax provision
|
|
$
|
65,073
|
|
|
$
|
43,739
|
|
A reconciliation of the statutory
federal income tax rate to the Company’s effective tax rate is a follows:
|
|
For the Three Months Ended March 31,
|
|
|
|
2018
|
|
|
2017
|
|
Tax at federal rate
|
|
|
21.0
|
%
|
|
|
34.0
|
%
|
U.S. income attributable to pass-through entity
|
|
|
0.0
|
%
|
|
|
-3.0
|
%
|
U.S. income subject to valuation allowance
|
|
|
-29.8
|
%
|
|
|
0.0
|
%
|
State and local income taxes
|
|
|
-0.3
|
%
|
|
|
0.0
|
%
|
Foreign income not subject to U.S. federal tax
|
|
|
7.6
|
%
|
|
|
-31.0
|
%
|
Foreign tax
|
|
|
-2.7
|
%
|
|
|
7.5
|
%
|
Effective income tax rate
|
|
|
-4.3
|
%
|
|
|
7.5
|
%
|
Note 5 — Notes Payable
The Company
entered into two debt instruments with current maturities of less than one year during the three months ended March 31, 2018.
The Company’s debt as of March 31, 2018 and December 31, 2017, net of debt discounts of $229,365 and $0, respectively, consisted
of the following:
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2018
|
|
|
2017
|
|
BHP Capital, 20% Original Issue Discount Debenture due July 2018, 0% interest
|
|
$
|
162,679
|
|
|
$
|
-
|
|
Horberg, 10% Original Issue Discount Senior Note due June 2018, 0% interest
|
|
|
307,956
|
|
|
|
-
|
|
Total notes payable
|
|
$
|
470,635
|
|
|
$
|
-
|
|
The d
ebenture
and senior note holders are entitled to receive 20,000 shares and 13,500 shares upon completion of the Company’s IPO,
respectively. The fair value of the shares to be issued was $167,500 which has been accrued with a corresponding reduction to
the debt liability and will be amortized through interest expense. The Company will issue these shares as soon as
administratively possible.
Note 6 —
Related Party Transactions
As of March 31, 2018 and 2017,
due to/from related party consists of amounts due to/from SRM Entertainment Group LLC (“SRM LLC”), which was the parent
of SRM prior to its acquisition by Xspand, related to operating expenses that were paid for on behalf of one related party to
the other related party. As of March 31, 2018 and December 31, 2017, the net amount due from related parties was $962,586 and
$834,897, respectively. Such amounts are due currently.
In connection
with the acquisition of SRM and Fergco, Xspand issued two notes payable aggregating $2,996,500. One note was issued to NL Penn
Capital, L.P, in relation to the acquisition of SRM in the amount of $2,120,000 and the other note was issued to the stockholders
of Fergco in the amount of $876,500. The notes bear interest at a rate of six percent (6%) per annum and have an effective interest
rate of six percent (6%) per annum. Xspand is required to make monthly payments comprised of principal and interest beginning
in January 2018 that are amortized over ten (10) years, with a balloon payment of all outstanding principal and interest due at
the respective maturity dates ($677,698 due on December 1, 2020 and $1,249,043 due on December 1, 2022). Related party interest
expense was $59,881 and $0 for the three months ended March 31, 2018 and 2017, respectively.
For the Years Ended March 31,
|
|
Amount
|
|
2018
|
|
$
|
239,689
|
|
2019
|
|
|
242,075
|
|
2020
|
|
|
909,143
|
|
2021
|
|
|
193,042
|
|
2022
|
|
|
1,384,308
|
|
|
|
$
|
2,968,257
|
|
Note
7 — Commitments and Contingencies
Operating
Lease
On August 8,
2016, SRM entered into a lease for office space in Kowloon, Hong Kong that expires on July 22, 2018. Monthly lease payments are
approximately $6,000 for a total of approximately $152,000 for the total term of the lease.
There were not
any future minimum payments under operating lease agreement that extended beyond 2018.
Total rent expense for the three
months ended March 31, 2018 and 2017 was $64,026 and $43,110, respectively, and is included in general and administrative expense
on the condensed consolidated statements of operations.
Rental Income
Fergco leases
a portion of the building located in Washington, New Jersey that it owns under a month to month lease. Total rental income related
to the leased space for both the three months ended March 31, 2018 and 2017 was $25,704, respectively, and is included in other
income on the condensed consolidated statements of operations.
Legal Contingencies
The Company may be involved
in claims and litigation in the ordinary course of business, some of which seek monetary damages, including claims for punitive
damages, which are not covered by insurance.
Xspand Products Lab,
Inc. and Subsidiaries
NOTES TO THE
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 8 —
Stockholders’ Equity
Stock-Based
Compensation
On
February 28, 2018, the Company agreed to assume certain consulting agreements entered into by SRM
LLC,
which was the parent of SRM prior to its acquisition by Xspand. Under these consulting agreements SRM LLC offered these
consultants options to own stock if SRM LLC were ever sold for past considerations. As an accommodation to Xspand, the
principal stockholder of SRM satisfied these agreements on behalf of the Company, by transferring 344,250 of his shares to
the consultants. In accordance with SEC Staff Accounting Bulletin (SAB) 79 amended by SAB 5T, “Accounting for Expenses
or Liabilities Paid by Principal Stockholder,” the Company recorded a noncash charge of $1,721,250 for the fair value
of these shares.
Note 9 —
Segment Reporting
The Company’s
principal operating segments coincide with the types of products to be sold. The products from which revenues are derived are consistent
with the reporting structure of the Company’s internal organization. The Company’s two reportable segments for the
three months ended March 31, 2018 and 2017 were the SRM segment and the Fergco segment. The Company’s chief operating decision-maker
has been identified as the Chairman and CEO, who reviews operating results to make decisions about allocating resources and assessing
performance for the entire Company. Segment information is presented based upon the Company’s management organization structure
as of March 31, 2018 and the distinctive nature of each segment. Future changes to this internal financial structure may result
in changes to the reportable segments disclosed. There are no inter-segment revenue transactions and, therefore, revenues are only
to external customers.
Segment operating
profit is determined based upon internal performance measures used by the chief operating decision-maker. The Company derives the
segment results from its internal management reporting system. The accounting policies the Company uses to derive reportable segment
results are the same as those used for external reporting purposes. Management measures the performance of each reportable segment
based upon several metrics, including net revenues, gross profit and operating loss. Management uses these results to evaluate
the performance of, and to assign resources to, each of the reportable segments. The Company manages certain operating expenses
separately at the corporate level and does not allocate such expenses to the segments. Segment income from operations excludes
interest income/expense and other income or expenses and income taxes according to how a particular reportable segment’s
management is measured. Management does not consider impairment charges, and unallocated costs in measuring the performance of
the reportable segments.
X
spand Products Lab, Inc.
and Subsidiaries
NOTES TO THE
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 9 —
Segment Reporting — (Continued)
Segment information
available with respect to these reportable business segments for the three months ended March 31, 2018 and 2017 was as follows:
|
|
For the Three Months Ended
March 31,
|
|
|
|
2018
|
|
|
2017
|
|
Revenues:
|
|
|
|
|
|
|
Fergco
|
|
$
|
1,306,919
|
|
|
$
|
1,298,771
|
|
SRM
|
|
|
2,124,411
|
|
|
|
2,563,005
|
|
Total segment and consolidated revenues
|
|
$
|
3,431,330
|
|
|
$
|
3,861,776
|
|
|
|
|
|
|
|
|
|
|
Gross profit:
|
|
|
|
|
|
|
|
|
Fergco
|
|
$
|
360,437
|
|
|
$
|
353,146
|
|
SRM
|
|
|
741,899
|
|
|
|
710,958
|
|
Total segment and consolidated gross profit
|
|
$
|
1,102,336
|
|
|
$
|
1,064,104
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations:
|
|
|
|
|
|
|
|
|
Fergco
|
|
$
|
57,594
|
|
|
$
|
24,688
|
|
SRM
|
|
|
547,253
|
|
|
|
531,597
|
|
Corporate
|
|
|
(2,055,248
|
)
|
|
|
-
|
|
Total segment and consolidated income (loss) from operations
|
|
$
|
(1,450,401
|
)
|
|
$
|
556,285
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
Fergco
|
|
$
|
27,767
|
|
|
$
|
34,086
|
|
SRM
|
|
|
11,864
|
|
|
|
17,381
|
|
Total segment depreciation and amortization
|
|
$
|
39,631
|
|
|
$
|
51,467
|
|
|
|
|
March 31,
|
|
|
|
December 31,
|
|
|
|
|
2018
|
|
|
|
2017
|
|
Segment total assets:
|
|
|
|
|
|
|
|
|
Fergco
|
|
$
|
1,893,586
|
|
|
$
|
1,853,273
|
|
SRM
|
|
|
3,035,398
|
|
|
|
2,217,296
|
|
Corporate
|
|
|
491,457
|
|
|
|
258
|
|
Total segment and consolidated assets
|
|
$
|
5,420,441
|
|
|
$
|
4,070,827
|
|
Note 10 —
Subsequent Events
On April
30, 2018, the Company completed its IPO of 1,307,120 shares of its common stock for aggregate gross proceeds of $6,535,600. The
Company received approximately $5,400,000 in net proceeds after deducting discounts and commissions and other offering
expenses.